BioSpace News Archive

Press Releases

TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY® as Part of Adjuvant Regimen for Patients with Early-Stage Non-Small Cell Lung Cancer at High Risk of Relapse

January 31, 2025
·
17 min read
Press Releases

IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess™)

January 31, 2025
·
6 min read
Press Releases

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England

January 31, 2025
·
5 min read
Press Releases

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma

January 31, 2025
·
19 min read
Press Releases

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

January 31, 2025
·
18 min read
Press Releases

Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader

January 31, 2025
·
14 min read
Press Releases

23andMe Launches New Genetic Report on Osteoporosis

January 31, 2025
·
5 min read
Press Releases

Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline

January 31, 2025
·
9 min read
Press Releases

Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025

January 31, 2025
·
9 min read
Press Releases

Immutep Quarterly Activities Report Q2 FY25

January 31, 2025
·
10 min read